Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Use of the Edmonton Injector for parenteral opioid management of cancer pain: a study of 100 consecutive patients.

Bruera E, Velasco-Leiva A, Spachynski K, Fainsinger R, Miller MJ, MacEachern T.

J Pain Symptom Manage. 1993 Nov;8(8):525-8.

PMID:
7525782
2.

The Edmonton injector: a simple device for patient-controlled subcutaneous analgesia.

Bruera E, MacMillan K, Hanson J, MacDonald RN.

Pain. 1991 Feb;44(2):167-9.

PMID:
2052383
3.

Hypodermoclysis (HDC) for symptom control vs. the Edmonton Injector (EI).

Fainsinger RL, Bruera E.

J Palliat Care. 1991 Winter;7(4):5-8.

PMID:
1783966
4.

A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.

Enting RH, Oldenmenger WH, van der Rijt CC, Wilms EB, Elfrink EJ, Elswijk I, Sillevis Smitt PA.

Cancer. 2002 Jun 1;94(11):3049-56.

5.

The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.

Reddy A, Tayjasanant S, Haider A, Heung Y, Wu J, Liu D, Yennurajalingam S, Reddy S, de la Cruz M, Rodriguez EM, Waletich J, Vidal M, Arthur J, Holmes C, Tallie K, Wong A, Dev R, Williams J, Bruera E.

Cancer. 2016 Jan 1;122(1):149-56. doi: 10.1002/cncr.29688. Epub 2015 Oct 9.

6.

I.v. infusion of opioids for cancer pain: clinical review and guidelines for use.

Portenoy RK, Moulin DE, Rogers A, Inturrisi CE, Foley KM.

Cancer Treat Rep. 1986 May;70(5):575-81.

PMID:
2423236
7.
8.

The opioid rotation ratio of hydrocodone to strong opioids in cancer patients.

Reddy A, Yennurajalingam S, Desai H, Reddy S, de la Cruz M, Wu J, Liu D, Rodriguez EM, Waletich J, Shin SH, Gayle V, Patel P, Dalal S, Vidal M, Tanco K, Arthur J, Tallie K, Williams J, Silvestre J, Bruera E.

Oncologist. 2014 Nov;19(11):1186-93. doi: 10.1634/theoncologist.2014-0130. Epub 2014 Oct 23.

9.

Use of the subcutaneous route for the administration of narcotics in patients with cancer pain.

Bruera E, Brenneis C, Michaud M, Bacovsky R, Chadwick S, Emeno A, MacDonald N.

Cancer. 1988 Jul 15;62(2):407-11.

10.

[Home care treatment of cancer pain patients with patient-controlled analgesia (PCA)].

Lux EA, Heine J.

Schmerz. 2011 Dec;25(6):663-7. doi: 10.1007/s00482-011-1101-9. German.

PMID:
21997184
11.
12.

Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer.

Bruera E, Legris MA, Kuehn N, Miller MJ.

J Pain Symptom Manage. 1990 Aug;5(4):218-20.

PMID:
2384700
13.

Pediatric palliative care: use of opioids for the management of pain.

Zernikow B, Michel E, Craig F, Anderson BJ.

Paediatr Drugs. 2009;11(2):129-51. doi: 10.2165/00148581-200911020-00004. Review.

PMID:
19301934
14.

[Patient-controlled analgesia (PCA) in outpatients with cancer pain. Analysis of 1,692 treatment days].

Schiessl C, Bidmon J, Sittl R, Griessinger N, Schüttler J.

Schmerz. 2007 Feb;21(1):35-8, 40-2. German.

PMID:
16955293
15.

Patient-controlled analgesia for children at home.

Mherekumombe MF, Collins JJ.

J Pain Symptom Manage. 2015 May;49(5):923-7. doi: 10.1016/j.jpainsymman.2014.10.007. Epub 2014 Dec 27.

PMID:
25546288
16.

Continuous sc infusion of narcotics using a portable disposable device in patients with advanced cancer.

Bruera E, Brenneis C, Michaud M, Chadwick S, MacDonald RN.

Cancer Treat Rep. 1987 Jun;71(6):635-7.

PMID:
2438040
17.

The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain.

Gagnon B, Bielech M, Watanabe S, Walker P, Hanson J, Bruera E.

Support Care Cancer. 1999 Jul;7(4):265-70.

PMID:
10423053
18.

A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain.

Nelson KA, Glare PA, Walsh D, Groh ES.

J Pain Symptom Manage. 1997 May;13(5):262-7.

PMID:
9185431
19.

Continuous subcutaneous infusions for pain control.

Poniatowski BC.

J Intraven Nurs. 1991 Jan-Feb;14(1):30-5.

PMID:
1990106
20.

Opioid analgesics in cancer pain: current practice and controversies.

Twycross RG.

Cancer Surv. 1988;7(1):29-53. Review.

PMID:
2454742

Supplemental Content

Support Center